Psoralen ameliorates sepsis-induced acute lung injury by regulating microbiota-dependent tryptophan metabolism
Phytomedicine · 2026
DOI: 10.1016/j.phymed.2026.158396 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Yunqi Kong und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China. Hauptthemen laut MEDLINE: Acute Lung Injury, Sepsis, Tryptophan, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Science and Technology Planning Project of Guangdong Province.
Themen: Sepsis
Abstract (Originalsprache)
BACKGROUND: Sepsis frequently leads to acute lung injury (ALI). Despite the documented anti-inflammatory effects of Psoralen (PSO), the exact mechanism by which it confers protection against septic ALI remains poorly understood. PURPOSE: This research explored the protective efficacy and mechanistic aspects of PSO in sepsis-induced ALI. METHODS: Lipopolysaccharide (LPS) was employed to create a murine ALI model. Pathological and inflammatory responses were evaluated. The dependency on gut microbiota was assessed through intestinal flora ablation and fecal microbiota transplantation. The aryl hydrocarbon receptor (AhR) engagement was demonstrated by its agonist FICZ and antagonist CH-223191. RESULTS: In a septic ALI model, PSO ameliorated the histopathological damage and attenuated the inflammatory response. Evidence for this included a lower lung neutrophil percentage and decreased amounts of the proinflammatory mediators tumor necrosis factor-α, interleukin-6, interleukin-1β, as well as MPO-DNA complexes. Additionally, PSO downregulated the abundance of key markers in pulmonary tissue, including peptidylarginine deiminase 4, colony-stimulating factor 2, citrullinated histone H3, and MPO, thereby suppressing neutrophil extracellular trap formation. Furthermore, PSO altered gut microbial diversity, an effect that relied on tryptophan metabolism originating from the gut microbiota. The treatment raised the relative abundance of indole-3-propionic acid (IPA) in serum, which subsequently triggered the AhR/CYP1A1 pathway and thereby alleviated ALI. Moreover, PSO enhanced intestinal tight junction protein expression. Nonetheless, these protective effects were abolished by the AhR inhibitor CH-223191.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.
- The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China; The Second Affiliated Hospital (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou University of Chinese Medici…
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Science and Technology Planning Project of Guangdong Province
Zitieren
APA
Kong, Y., Feng, J., Xu, H., Chen, X., Huo, W., Pan, S., Wang, Q., Chen, J., Liu, Y., Li, J., & Lu, Y. (2026). Psoralen ameliorates sepsis-induced acute lung injury by regulating microbiota-dependent tryptophan metabolism. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.158396
Vancouver
Kong Y, Feng J, Xu H, Chen X, Huo W, Pan S, et al. Psoralen ameliorates sepsis-induced acute lung injury by regulating microbiota-dependent tryptophan metabolism. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.158396
BibTeX
@article{Kong2026,
author = {Kong, Yunqi and Feng, Jieni and Xu, Haoxiang and Chen, Xueru and Huo, Wanhua and Pan, Simin and Wang, Qiuyue and Chen, Jiankun and Liu, Yuntao and Li, Jiqiang and Lu, Yue},
title = {Psoralen ameliorates sepsis-induced acute lung injury by regulating microbiota-dependent tryptophan metabolism},
journal = {Phytomedicine},
year = {2026},
doi = {10.1016/j.phymed.2026.158396}
}
EUVIMED